SigTuple has raised $4 Mn (over INR 33.5 Cr) in an extended series C funding round led by Sidbi Venture Capital, and from its existing investors
The company is planning to deploy the newly raised funds to expand its geographical footprint, broaden product portfolio and support regulatory clearances
The Bengaluru-based company raised $4.3 Mn led by its existing investors Endiya Partners and Accel to expand its geographical footprint and product portfolio, in 2023
Medtech startup SigTuple
has raised $4 Mn (over INR 33.5 Cr) in an extended series C funding round led by Sidbi Venture Capital.
As per ET’s report, the round also saw participation from its existing investors, including Endiya Partners, among others.
The report said the company is planning to deploy the newly raised funds to expand its geographical footprint, broaden product portfolio and support regulatory clearances.
Inc42 has reached out to SigTuple for comments on the development. The story will be updated based on the response.
Founded in 2015 by Apurv Anand, Bharath Cheluvaraju, Rohit Kumar Pandey and Tathagato Dastidar, SigTuple makes AI-driven smart robotic microscopes to automate the manual process in clinical laboratories.
The medtech company is backed by Accel Partners, Chiratae Ventures, Endiya Partners, pi Ventures, Venture Highway, and a few others.
Prior to the current round of funding, the Bengaluru-based medtech company raised $4.3 Mn in a fresh funding round led by its existing investors Endiya Partners and Accel to expand its geographical footprint and product portfolio, over a year ago.
SigTuple also has plans to enter the point-of-care (PoC) market in the following year, to leverage into microfluidic technology and imaging to conduct essential tests within minutes, the report said.
Healthtech companies have been in the race of expanding their operations to new locations and have consistently made efforts to raise funds this year.
Earlier today, online healthcare service provider Visit Health secured INR 250 Cr (nearly $29.8 Mn) from PB Fintech’s arm Docprime Technologies in a mix of capital infusion and secondary purchase of shares.
